Restructuring Pharmaceutical Global Supply Chains after COVID-19

Raghbendra Jha, Ashok Sharma

Research output: Contribution to Newspaper/Magazine/BulletinArticle

Abstract

The COVID-19 outbreak provides India’s pharmaceutical industry a big opportunity, but responsibility as well. India is poised to be a key destination for manufacturing alternatives as the world looks to diversify the global supply chain away from China.
Original languageEnglish
Pages1-3
Number of pages3
Specialist publicationAustralian Journal of International Affairs
PublisherAustralian Institute of International Affairs
Publication statusPublished - 21 May 2020

Fingerprint Dive into the research topics of 'Restructuring Pharmaceutical Global Supply Chains after COVID-19'. Together they form a unique fingerprint.

  • Cite this